wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39297345-3FDC60E4-BBF0-4DEE-8594-F745D5933E3D
Q39297345-3FDC60E4-BBF0-4DEE-8594-F745D5933E3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39297345-3FDC60E4-BBF0-4DEE-8594-F745D5933E3D
A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure.
P2860
Q39297345-3FDC60E4-BBF0-4DEE-8594-F745D5933E3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39297345-3FDC60E4-BBF0-4DEE-8594-F745D5933E3D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
29fc26a289af609dbb57d6df56a74e6d28e70c13
P2860
Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling.